§ Mr. SkinnerTo ask the Secretary of State for Health if he will list the amount of funding provided for research into(a) breast cancer, (b) childhood leukaemia, (c) cervical cancer, (d) prostate cancer, (e) colon cancer and (f) lung cancer for the last five years for which figures are available. [58104]
§ Ms JowellThe Government fund health and medical research in a number of ways:
The Department funds research and development to support its work on policy development and evaluation in health and social care. The Department also manages the National Health Service research and development levy which is used to support research and development of 86W relevance to the NHS both in NHS hospitals, general practice and other health care settings, and to fund the NHS research and development programme.
In addition, the Medical Research Council, which receives most of its income via grant-in-aid from the Office of Science and Technology in the Department of Trade and Industry, funds medical research as part of the Government's funding of the research base. The Scottish Office Department of Health (SO) also fund research.
Industry and medical research charities also make a substantial investment in cancer research.
Central records show:
£000 1993–94 1994–95 1995–96 1996–97 1997–98 Breast cancer DH2 725 888 972 953 832 MRC3 1n/a 3,641 2,854 3,098 3,328 SO 111 148 306 274 179 All leukaemia4 DH2 — — — — 48 MRC 1n/a 2,925 2,780 2,384 2,527 Childhood leukaemia SO 3 0 14 15 32 Cervical cancer DH2 99 66 0 0 0 MRC3 1n/a 432 445 543 460 SO 14 0 0 0 0 Prostate cancer DH2 1n/a 8 69 68 29 MRC3 1n/a 0 0 73 18 SO 0 0 0 0 0 Colon cancer (Bowel cancer) DH2 46 37 35 209 197 MRC3 1n/a 623 873 1,207 1,469 SO 85 59 64 81 100 Lung cancer DH2 100 160 171 428 187 MRC3 1n/a 990 718 691 691 SO 0 12 43 35 0 1n/a indicates figures not available. 2Further funding may be being provided by the Department of Health through the NHS R&D Levy—detailed information about which is not held centrally. 3The MRC are also supporting 11 trials in the relevant cancers. The MRC also funds basic research including the study of molecules and cells, genetics and infections and immunity which will inform research in this area. 4 It is not possible to disaggregate figures for childhood leukaemia. Notes:
The fluctuation in levels of spend reflects the cycle of commissioning as projects start and finish.